Compare Moderna, Inc. (MRNA) vs Palantir Technologies Inc (PLTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Palantir Technologies Inc — how do they compare? Moderna, Inc. trades at $60.77 (market cap $24.18B), while Palantir Technologies Inc trades at $171.8 (market cap $420.39B). The key difference: Palantir Technologies Inc is far larger — about 17.4× Moderna, Inc.'s market cap. Which is the better fit depends on your goals.
| MRNA | PLTR | |
|---|---|---|
Market Cap | $24.18B | $420.39B |
Sector | Health | Technology |
52-Week High | $81.80 | $207.18 |
52-Week Low | $22.36 | $107.27 |
Enterprise Value | $20.33B | $411.19B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Palantir Technologies Inc
Palantir Technologies provides organizations with solutions to manage large disparate data sets in an attempt to gain insight and drive operational outcomes. Founded in 2003, Palantir released its Gotham software platform in 2008, which focuses on the government intelligence and defense sectors. Palantir expanded into various commercial markets with its Foundry software platform in 2016 with the intent of becoming the data operating system for companies and industries. The Denver company had 125 customers as of its initial public offering and roughly splits its revenue between commercial and government customers.
Read more on PLTR →
